Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Evaluation of anti-metastatic potential of Cisplatin polymeric nanocarriers on B16F10 melanoma cells.

Shrikhande SS, Jain DS, Athawale RB, Bajaj AN, Goel P, Kamran Z, Nikam Y, Gude R.

Saudi Pharm J. 2015 Sep;23(4):341-51. doi: 10.1016/j.jsps.2014.08.004. Epub 2015 Jan 6.

2.

Thermosensitive PLA based nanodispersion for targeting brain tumor via intranasal route.

Jain DS, Bajaj AN, Athawale RB, Shikhande SS, Pandey A, Goel PN, Gude RP, Patil S, Raut P.

Mater Sci Eng C Mater Biol Appl. 2016 Jun;63:411-21. doi: 10.1016/j.msec.2016.03.015. Epub 2016 Mar 6.

PMID:
27040235
3.

Endogenous galectin-3 expression levels modulate immune responses in galectin-3 transgenic mice.

Chaudhari AD, Gude RP, Kalraiya RD, Chiplunkar SV.

Mol Immunol. 2015 Dec;68(2 Pt A):300-11. doi: 10.1016/j.molimm.2015.09.015. Epub 2015 Oct 9.

PMID:
26442663
4.

LeciPlex, invasomes, and liposomes: A skin penetration study.

Shah SM, Ashtikar M, Jain AS, Makhija DT, Nikam Y, Gude RP, Steiniger F, Jagtap AA, Nagarsenker MS, Fahr A.

Int J Pharm. 2015 Jul 25;490(1-2):391-403. doi: 10.1016/j.ijpharm.2015.05.042. Epub 2015 May 19.

PMID:
26002568
5.

Role of tumor cell surface lysosome-associated membrane protein-1 (LAMP1) and its associated carbohydrates in lung metastasis.

Agarwal AK, Srinivasan N, Godbole R, More SK, Budnar S, Gude RP, Kalraiya RD.

J Cancer Res Clin Oncol. 2015 Sep;141(9):1563-74. doi: 10.1007/s00432-015-1917-2. Epub 2015 Jan 23.

PMID:
25614122
6.

Development and implementation of a decision pathway for general practitioners for the management or referral of suspected allergy.

Jones RB, Ashurst EJ, Jones D, Gude R, Kaminski E.

J Public Health Res. 2014 Jul 1;3(2):248. doi: 10.4081/jphr.2014.248. eCollection 2014 Jul 2.

7.

Docetaxel in cationic lipid nanocapsules for enhanced in vivo activity.

Jain AS, Makhija DT, Goel PN, Shah SM, Nikam Y, Gude RP, Jagtap AG, Nagarsenker MS.

Pharm Dev Technol. 2016;21(1):76-85. doi: 10.3109/10837450.2014.971374. Epub 2014 Oct 20.

PMID:
25329444
8.

Liposomes for targeting hepatocellular carcinoma: use of conjugated arabinogalactan as targeting ligand.

Shah SM, Goel PN, Jain AS, Pathak PO, Padhye SG, Govindarajan S, Ghosh SS, Chaudhari PR, Gude RP, Gopal V, Nagarsenker MS.

Int J Pharm. 2014 Dec 30;477(1-2):128-39. doi: 10.1016/j.ijpharm.2014.10.014. Epub 2014 Oct 11.

PMID:
25311181
9.

Apoptosis induction and anti-cancer activity of LeciPlex formulations.

Dhawan VV, Joshi GV, Jain AS, Nikam YP, Gude RP, Mulherkar R, Nagarsenker MS.

Cell Oncol (Dordr). 2014 Oct;37(5):339-51. doi: 10.1007/s13402-014-0183-7. Epub 2014 Sep 10.

PMID:
25204961
10.

Surface-coated PLA nanoparticles loaded with temozolomide for improved brain deposition and potential treatment of gliomas: development, characterization and in vivo studies.

Jain D, Bajaj A, Athawale R, Shrikhande S, Goel PN, Nikam Y, Gude R, Patil S, Prashant Raut P.

Drug Deliv. 2016;23(3):999-1016. doi: 10.3109/10717544.2014.926574. Epub 2014 Jul 15.

PMID:
25026415
11.

Galectin-3 expressed on different lung compartments promotes organ specific metastasis by facilitating arrest, extravasation and organ colonization via high affinity ligands on melanoma cells.

Dange MC, Srinivasan N, More SK, Bane SM, Upadhya A, Ingle AD, Gude RP, Mukhopadhyaya R, Kalraiya RD.

Clin Exp Metastasis. 2014 Aug;31(6):661-73. doi: 10.1007/s10585-014-9657-2. Epub 2014 Jun 21.

PMID:
24952269
12.

Regulation of melanoma metastasis to lungs by cell surface Lysosome Associated Membrane Protein-1 (LAMP1) via galectin-3.

Agarwal AK, Gude RP, Kalraiya RD.

Biochem Biophys Res Commun. 2014 Jul 4;449(3):332-7. doi: 10.1016/j.bbrc.2014.05.028. Epub 2014 May 15.

PMID:
24845565
13.

Anti-neuropilin 1 antibody Fab' fragment conjugated liposomal docetaxel for active targeting of tumours.

Manjappa AS, Goel PN, Gude RP, Ramachandra Murthy RS.

J Drug Target. 2014 Sep;22(8):698-711. doi: 10.3109/1061186X.2014.910792. Epub 2014 Apr 28.

PMID:
24766186
14.

Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: in vitro and in vivo evaluation.

Jain AS, Goel PN, Shah SM, Dhawan VV, Nikam Y, Gude RP, Nagarsenker MS.

Biomed Pharmacother. 2014 May;68(4):429-38. doi: 10.1016/j.biopha.2014.03.004. Epub 2014 Mar 18.

PMID:
24721327
15.

Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung.

Athawale RB, Jain DS, Singh KK, Gude RP.

Biomed Pharmacother. 2014 Mar;68(2):231-40. doi: 10.1016/j.biopha.2014.01.004. Epub 2014 Jan 25.

PMID:
24560352
16.

Unraveling the cytotoxic potential of Temozolomide loaded into PLGA nanoparticles.

Jain DS, Athawale RB, Bajaj AN, Shrikhande SS, Goel PN, Nikam Y, Gude RP.

Daru. 2014 Jan 10;22(1):18. doi: 10.1186/2008-2231-22-18.

17.

Delineating the anti-metastatic potential of pentoxifylline in combination with liposomal doxorubicin against breast cancer cells.

Goel PN, Gude RP.

Biomed Pharmacother. 2014 Mar;68(2):191-200. doi: 10.1016/j.biopha.2013.11.003. Epub 2013 Dec 2.

PMID:
24373697
18.

Pentoxifylline regulates the cellular adhesion and its allied receptors to extracellular matrix components in breast cancer cells.

Goel PN, Gude RP.

Biomed Pharmacother. 2014 Feb;68(1):93-9. doi: 10.1016/j.biopha.2013.09.002. Epub 2013 Oct 8.

PMID:
24269001
19.

Role of STAT3 in cancer metastasis and translational advances.

Kamran MZ, Patil P, Gude RP.

Biomed Res Int. 2013;2013:421821. doi: 10.1155/2013/421821. Epub 2013 Oct 2. Review.

20.

Lipid colloidal carriers for improvement of anticancer activity of orally delivered quercetin: formulation, characterization and establishing in vitro-in vivo advantage.

Jain AS, Shah SM, Nagarsenker MS, Nikam Y, Gude RP, Steiniger F, Thamm J, Fahr A.

J Biomed Nanotechnol. 2013 Jul;9(7):1230-40.

PMID:
23909137
21.

Curbing the focal adhesion kinase and its associated signaling events by pentoxifylline in MDA-MB-231 human breast cancer cells.

Goel PN, Gude RP.

Eur J Pharmacol. 2013 Aug 15;714(1-3):432-41. doi: 10.1016/j.ejphar.2013.07.004. Epub 2013 Jul 16.

PMID:
23872375
22.

Is an alternative drug delivery system needed for docetaxel? The role of controlling epimerization in formulations and beyond.

Manjappa AS, Goel PN, Vekataraju MP, Rajesh KS, Makwana K, Ukawala M, Nikam Y, Gude RP, Murthy RS.

Pharm Res. 2013 Oct;30(10):2675-93. doi: 10.1007/s11095-013-1093-5. Epub 2013 Jun 12.

PMID:
23756759
23.

Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway.

Kamran MZ, Gude RP.

Biomed Pharmacother. 2013 Jun;67(5):399-405. doi: 10.1016/j.biopha.2013.03.020. Epub 2013 Apr 17.

PMID:
23639230
24.

Type II phosphatidylinositol 4-kinase β is an integral signaling component of early T cell activation mechanisms.

Sinha RK, Bojjireddy N, Kulkarni D, Ratheesh A, Chiplunkar SV, Gude R, Subrahmanyam G.

Biochimie. 2013 Aug;95(8):1560-6. doi: 10.1016/j.biochi.2013.04.005. Epub 2013 Apr 23.

PMID:
23619705
25.

Studies on stabilization mechanism and stealth effect of poloxamer 188 onto PLGA nanoparticles.

Jain D, Athawale R, Bajaj A, Shrikhande S, Goel PN, Gude RP.

Colloids Surf B Biointerfaces. 2013 Sep 1;109:59-67. doi: 10.1016/j.colsurfb.2013.03.027. Epub 2013 Mar 28.

PMID:
23608470
26.

Tyrosine kinase inhibitor AG490 inhibits the proliferation and migration and disrupts actin organization of cancer cells.

Kamran MZ, Patil P, Shirsath K, Gude RP.

J Environ Pathol Toxicol Oncol. 2013;32(4):361-71.

PMID:
24579787
27.

Re-evaluate the effect of hyperbaric oxygen therapy in cancer - a preclinical therapeutic small animal model study.

Pande S, Sengupta A, Srivastava A, Gude RP, Ingle A.

PLoS One. 2012;7(11):e48432. doi: 10.1371/journal.pone.0048432. Epub 2012 Nov 7.

28.

Preclinical evaluation of the antimetastatic efficacy of Pentoxifylline on A375 human melanoma cell line.

Kamran MZ, Gude RP.

Biomed Pharmacother. 2012 Dec;66(8):617-26. doi: 10.1016/j.biopha.2012.03.006. Epub 2012 Apr 11.

PMID:
23089470
29.

MTA1-mediated transcriptional repression of SMAD7 in breast cancer cell lines.

Salot S, Gude R.

Eur J Cancer. 2013 Jan;49(2):492-9. doi: 10.1016/j.ejca.2012.06.019. Epub 2012 Jul 25.

PMID:
22841502
30.

Fascin overexpression promotes neoplastic progression in oral squamous cell carcinoma.

Alam H, Bhate AV, Gangadaran P, Sawant SS, Salot S, Sehgal L, Dange PP, Chaukar DA, D'cruz AK, Kannanl S, Gude R, Kane S, Dalal SN, Vaidya MM.

BMC Cancer. 2012 Jan 20;12:32. doi: 10.1186/1471-2407-12-32.

31.

Laminin receptor-targeted etoposide loaded polymeric micelles: a novel approach for the effective treatment of tumor metastasis.

Ukawala M, Chaudhari K, Rajyaguru T, Manjappa AS, Murthy RS, Gude R.

J Drug Target. 2012 Jan;20(1):55-66. doi: 10.3109/1061186X.2011.610799. Epub 2011 Oct 4.

PMID:
21967151
32.

Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells.

Goel PN, Gude RP.

Mol Cell Biochem. 2011 Dec;358(1-2):141-51. doi: 10.1007/s11010-011-0929-8. Epub 2011 Jul 3.

PMID:
21725843
33.

Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration.

Date AA, Nagarsenker MS, Patere S, Dhawan V, Gude RP, Hassan PA, Aswal V, Steiniger F, Thamm J, Fahr A.

Mol Pharm. 2011 Jun 6;8(3):716-26. doi: 10.1021/mp100305h. Epub 2011 Apr 20.

PMID:
21480639
34.

EILDV-conjugated, etoposide-loaded biodegradable polymeric micelles directing to tumor metastatic cells overexpressing α4β1 integrin.

Ukawala M, Rajyaguru T, Chaudhari K, Manjappa AS, Murthy RS, Gude R.

Cancer Nanotechnol. 2011;2(1-6):133-145. Epub 2011 Sep 15.

35.
36.

RP-HPLC Estimation of Ramipril and Telmisartan in Tablets.

Kurade VP, Pai MG, Gude R.

Indian J Pharm Sci. 2009 Mar;71(2):148-51. doi: 10.4103/0250-474X.54283.

37.

Pentoxifylline inhibits integrin-mediated adherence of 12(S)-HETE and TNFalpha-activated B16F10 cells to fibronectin and endothelial cells.

Jain M, Ratheesh A, Gude RP.

Chemotherapy. 2010;56(1):82-8. doi: 10.1159/000298823. Epub 2010 Mar 19.

PMID:
20299795
38.

Paclitaxel-loaded glyceryl palmitostearate nanoparticles: in vitro release and cytotoxic activity.

Shenoy VS, Gude RP, Murthy RS.

J Drug Target. 2009 May;17(4):304-10. doi: 10.1080/10611860902737938.

PMID:
19255897
39.

Studies on paclitaxel-loaded glyceryl monostearate nanoparticles.

Shenoy VS, Rajyaguru TH, Gude RP, Murthy RS.

J Microencapsul. 2009 Sep;26(6):471-8. doi: 10.1080/02652040802379902.

PMID:
19169921
40.

Pentoxifylline impedes migration in B16F10 melanoma by modulating Rho GTPase activity and actin organisation.

Dua P, Gude RP.

Eur J Cancer. 2008 Jul;44(11):1587-95. doi: 10.1016/j.ejca.2008.04.009. Epub 2008 May 19.

PMID:
18495474
41.
42.
43.

Antiproliferative and antiproteolytic activity of pentoxifylline in cultures of B16F10 melanoma cells.

Dua P, Gude RP.

Cancer Chemother Pharmacol. 2006 Aug;58(2):195-202. Epub 2005 Dec 6.

PMID:
16331498
44.

Resveratrol inhibits type II phosphatidylinositol 4-kinase: a key component in pathways of phosphoinositide turn over.

Srivastava R, Ratheesh A, Gude RK, Rao KV, Panda D, Subrahmanyam G.

Biochem Pharmacol. 2005 Oct 1;70(7):1048-55.

PMID:
16102733
46.

Amelioration of B16F10 melanoma cells induced oxidative stress in DBA/2 mice by pentoxifylline.

Shukla V, Gude RP.

J Exp Clin Cancer Res. 2003 Sep;22(3):407-10.

PMID:
14582699
47.
49.

Tumor regression of B16F10 melanoma in vivo by prevention of neovascularization: study on theophylline.

Menon LG, Ingle AD, Gude RP.

Cancer Biother Radiopharm. 2002 Apr;17(2):213-7.

PMID:
12030115
50.

Supplemental Content

Support Center